Cargando…

A randomized clinical pharmacokinetic trial of Tenofovir in blood, plasma and urine in adults with perfect, moderate and low PrEP adherence: the TARGET study

BACKGROUND: Tenofovir disoproxil fumarate (TDF) is key component of pre-exposure prophylaxis (PrEP) and antiretroviral therapy (ART) for HIV, but existing tools to monitor drug adherence are often inaccurate. Detection of tenofovir (TFV) in accessible biological samples, such as fingerprick blood, u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cressey, Tim R., Siriprakaisil, Oraphan, Klinbuayaem, Virat, Quame-Amaglo, Justice, Kubiak, Rachel W., Sukrakanchana, Pra-ornsuda, Than-in-at, Kanchana, Baeten, Jared, Sirirungsi, Wasna, Cressey, Ratchada, Drain, Paul K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5513124/ https://www.ncbi.nlm.nih.gov/pubmed/28705153 http://dx.doi.org/10.1186/s12879-017-2593-4

Ejemplares similares

Tenofovir-Diphosphate in Dried Blood Spots vs Tenofovir in Urine/Plasma for Oral Preexposure Prophylaxis Adherence Monitoring
por: Niu, Xin, et al.
Publicado: (2022)

Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes
por: Bardon, Ashley R, et al.
Publicado: (2021)

Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
por: Jourdain, Gonzague, et al.
Publicado: (2016)

HIV RNA measurement in dried blood spots of HIV-infected patients in Thailand using Abbott m2000 system
por: Khamduang, Woottichai, et al.
Publicado: (2020)

Pharmacokinetics and Safety of the Abacavir/Lamivudine/Lopinavir/Ritonavir Fixed-Dose Granule Formulation (4-in-1) in Neonates: PETITE Study
por: Bekker, Adrie, et al.
Publicado: (2022)

Alteration of protein expression pattern of vascular endothelial growth factor (VEGF) from soluble to cell-associated isoform during tumourigenesis
por: Cressey, Ratchada, et al.
Publicado: (2005)

Knockout of glucosidase II beta subunit inhibits growth and metastatic potential of lung cancer cells by inhibiting receptor tyrosine kinase activities
por: Khaodee, Worapong, et al.
Publicado: (2019)

Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
por: Johnson, Kelly A, et al.
Publicado: (2021)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

Delivery of Community-based Antiretroviral Therapy to Maintain Viral Suppression and Retention in Care in South Africa
por: Wang, Melody, et al.
Publicado: (2023)

Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015
por: Ngo-Giang-Huong, Nicole, et al.
Publicado: (2021)

Simplified approaches for the development of an ELISA to detect circulating autoantibodies to p53 in cancer patients
por: Cressey, Ratchada, et al.
Publicado: (2008)

Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study
por: Dorward, Jienchi, et al.
Publicado: (2017)

Not so secure after all
por: Cressey, Daniel
Publicado: (2007)

HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention
por: Donnell, Deborah, et al.
Publicado: (2014)

A Report on the Standardization of the Witmer Cylinder Test
por: Paschal, Franklin Cressey
Publicado: (1918)

Continued attendance in a PrEP program despite low adherence and non-protective drug levels among adolescent girls and young women in Kenya: Results from a prospective cohort study
por: Tapsoba, Jean de Dieu, et al.
Publicado: (2022)

Incidence of Tuberculosis and Associated Mortality in a Cohort of Human Immunodeficiency Virus-Infected Children Initiating Antiretroviral Therapy
por: Salvadori, Nicolas, et al.
Publicado: (2017)

Understanding staff perspectives of quality in practice in healthcare
por: Farr, Michelle, et al.
Publicado: (2015)

Switching HIV Treatment in Adults Based on CD4 Count Versus Viral Load Monitoring: A Randomized, Non-Inferiority Trial in Thailand
por: Jourdain, Gonzague, et al.
Publicado: (2013)

Tierras y pueblos de Asia /
por: Cressey, George Babcock, 1896-1963
Publicado: (1946)

Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial
por: Celum, Connie L, et al.
Publicado: (2020)

Protocol for a longitudinal study to evaluate the use of tenofovir-based PrEP for safer conception and pregnancy among women in South Africa
por: Matthews, Lynn T, et al.
Publicado: (2019)

Potential role of the common food additive manufactured citric acid in eliciting significant inflammatory reactions contributing to serious disease states: A series of four case reports
por: Sweis, Iliana E., et al.
Publicado: (2018)

RUDRAKSHA THERAPY FOR PERFECT HEALTH
por: Rao, Justice I. Panduranga, et al.
Publicado: (1995)

Papulonodular Secondary Syphilis Presenting as Multiple Distinct Cutaneous Lesions in an HIV-Positive Transgender Woman
por: Navrazhina, Kristina, et al.
Publicado: (2017)

Pilot evaluation of an enzymatic assay for rapid measurement of antiretroviral drug concentrations
por: Olanrewaju, Ayokunle O., et al.
Publicado: (2021)

Nicolau syndrome after lumbar puncture: A case report in a 22-month-old girl
por: Navrazhina, Kristina, et al.
Publicado: (2017)

Temper outbursts in Lowe syndrome: Characteristics, sequence, environmental context and comparison to Prader–Willi syndrome
por: Cressey, Helen, et al.
Publicado: (2019)

The Safety of Tenofovir–Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
por: Solomon, Marc M., et al.
Publicado: (2016)

Testing a Real-Time Tenofovir Urine Adherence Assay for Monitoring and Providing Feedback to Preexposure Prophylaxis in Kenya (PUMA): Protocol for a Pilot Randomized Controlled Trial
por: Drain, Paul, et al.
Publicado: (2020)

Development and Validation of an Immunoassay for Tenofovir in Urine as a Real-Time Metric of Antiretroviral Adherence
por: Gandhi, Monica, et al.
Publicado: (2018)

Improvement of chronic corneal opacity in ocular surface disease with prosthetic replacement of the ocular surface ecosystem (PROSE) treatment
por: Cressey, Anna, et al.
Publicado: (2018)

Pharmacy delivery to expand the reach of PrEP in Africa
por: Ortblad, Katrina F, et al.
Publicado: (2020)

Performance and Stability of Tenofovir Alafenamide Formulations within Subcutaneous Biodegradable Implants for HIV Pre-Exposure Prophylaxis (PrEP)
por: Li, Linying, et al.
Publicado: (2020)

Response to “Being prepared to evaluate pregnancy PrEP”
por: Dettinger, Julia C, et al.
Publicado: (2019)

Characterization of a Reservoir-Style Implant for Sustained Release of Tenofovir Alafenamide (TAF) for HIV Pre-Exposure Prophylaxis (PrEP)
por: Johnson, Leah M., et al.
Publicado: (2019)

Association Between Physical Activity and Type 2 Diabetes Using the International Physical Activity Questionnaires: A Case-Control Study at a Health Promoting Hospital in Chiang Mai, Northern Thailand
por: Sodeno, Miho, et al.
Publicado: (2022)

Knowledge and barriers of PrEP delivery among diverse groups of potential PrEP users in Central Uganda
por: Muwonge, Timothy R., et al.
Publicado: (2020)

Daily HIV pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate-emtricitabine reduced Streptococcus and increased Erysipelotrichaceae in rectal microbiota
por: Dubé, Michael P., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6khtvbegjqdf8lqogtp3ec3lnu